What is iRadimed's R&D?

iRadimed (IRMD) reported R&D of $956K in Q1 2026.

How has iRadimed's R&D changed year-over-year?

iRadimed's R&D increased by 53.2% year-over-year, from $624K to $956K.

What is the long-term trend for iRadimed's R&D?

Over 4 years (2021 to 2025), iRadimed's R&D has grown at a 11.8% compound annual growth rate (CAGR), from $1.91M to $2.97M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

iRadimed IRMD R&D

R&D at other companies

GE HealthCare TechnologiesGEHC

$345M+0.3%

Merit Medical SystemsMMSI

$22.61M+0.6%

ICU MedicalICUI

$21.28M-8.6%

ITG

Integer HoldingsITGR

$16.24M+14.4%

iRhythm Holdings, Inc. IRTC

$21.36M-0.7%

PROCEPT BioRobotics CorporationPRCT

$21.47M+30.9%

Other financials

Income statement

See full

Revenue$22.0M+12.6%

Gross profit$16.8M+13.3%

Operating income$7.2M+33.2%

Net income$5.8M+24.1%

EPS (diluted)$0.45+21.6%

Balance sheet

See full

Cash & equivalents$56.4M+12.0%

Total debt$59.2K-96.9%

Total equity$98.5M+9.4%

Total assets$114.4M+12.4%

Cash flow

See full

Operating cash flow$8.3M+93.2%

CapEx$403.0K-89.1%

Free cash flow$7.9M+1,226%

Valuation

See full

Market cap$1.21B+63.4%

P/E51.3×+13.8×

P/S14×+4.2×

Profitability

See full

Gross margin76.8%-0.1pp

Operating margin32.4%+2.3pp

Net margin27.4%+1.0pp

FCF margin28.4%+8.9pp

Returns & leverage

See full

Return on equity25%+1.2pp

Debt / equity0×0.0×

Current ratio7.1×-1.7×

Where this comes from

Reported directly by iRadimed in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is iRadimed's R&D?: iRadimed (IRMD) reported R&D of $956K in Q1 2026.
How has iRadimed's R&D changed year-over-year?: iRadimed's R&D increased by 53.2% year-over-year, from $624K to $956K.
What is the long-term trend for iRadimed's R&D?: Over 4 years (2021 to 2025), iRadimed's R&D has grown at a 11.8% compound annual growth rate (CAGR), from $1.91M to $2.97M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.